As timelines from DNA to IND continue to shorten, the need for faster toxicology material delivery has become increasingly important to start studies as early as possible and avoid delays in IND submissions.
Sponsored by:
On Demand Webinars
Rapid delivery of toxicological study material: The new critical path for accelerating biopharmaceutical drug development
Articles
Breaking the toxicology bottleneck for IND submissions
With increasingly rapid timelines for achieving IND-ready processes, a bottleneck has emerged in the provision of toxicology data to support INDs for new therapeutics and hence delivery of FIH studies, as Alejandro Fernandez Martell and James Berrie explain in this article originally published in Drug Target Review.
Accelerating the path to clinical filing applications with rapid toxicology material delivery
The application for investigational new drug (IND) and Clinical Trial Application (CTA) is a key step in initiating clinical trials/first-in-human (FIH) trials for a drug candidate.
White Papers
Q&A on Large-Scale Commercial Expansion at Lonza's Stein Facility
Explore the Q&A to see how Lonza’s integrated network and proven tech transfer expertise (>50 projects in the past 12 months) can help you manufacture efficiently and bring therapies to market faster.
Industry-backed data-driven approaches to enhancing container closure integrity
Strengthen Container Closure Integrity Across the Drug Product Lifecycle
Empower Your ADC Drug Product Tech Transfer
This white paper provides a comprehensive overview of the challenges and solutions associated with technology transfer for antibody-drug conjugate (ADC) drug product manufacturing.
Strengthen Container Closure Integrity Across the Drug Product Lifecycle
Maintaining container closure integrity (CCI) is essential to ensure the safety, quality, and efficacy of sterile drug products.
Accelerate Tox Material Delivery and Stay on Track for IND Submission
As development timelines tighten, generating toxicology (tox) data quickly has become a critical milestone on the path to IND submission.